RETROVIR, a drug licensed in Britain for treating people with AIDS or
other symptoms of infection with HIV, may soon be available for treating
people with HIV who have shown no sign of illness. The Wellcome Foundation,
the British pharmaceuticals company, announced this week that it had won
provisional clearance from the Committee for Proprietary Medicinal Products
of the European Commission to seek wider use for Retrovir. Individual member
states of the EC are now considering the committee鈥檚 recommendations.
More from New Scientist
Explore the latest news, articles and features
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Mind
THC in cannabis may reduce nightmares in people with PTSD
News
Environment
Fishers detonate a bomb every hour on one Indonesian coral reef
News
Environment
How bad is the UK drought and how long will it continue?
News
Popular articles
Trending New Scientist articles